ATE485374T1 - Lignan-glykosidase und deren nutzung - Google Patents

Lignan-glykosidase und deren nutzung

Info

Publication number
ATE485374T1
ATE485374T1 AT05803357T AT05803357T ATE485374T1 AT E485374 T1 ATE485374 T1 AT E485374T1 AT 05803357 T AT05803357 T AT 05803357T AT 05803357 T AT05803357 T AT 05803357T AT E485374 T1 ATE485374 T1 AT E485374T1
Authority
AT
Austria
Prior art keywords
lignan
enzyme
glycosidase
identifying
polypeptide
Prior art date
Application number
AT05803357T
Other languages
English (en)
Inventor
Eiichiro Ono
Yoshikazu Tanaka
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Application granted granted Critical
Publication of ATE485374T1 publication Critical patent/ATE485374T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8255—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05803357T 2004-11-02 2005-11-02 Lignan-glykosidase und deren nutzung ATE485374T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004319624A JP4667007B2 (ja) 2004-11-02 2004-11-02 リグナン配糖化酵素およびその利用
PCT/JP2005/020495 WO2006049315A1 (ja) 2004-11-02 2005-11-02 リグナン配糖化酵素およびその利用

Publications (1)

Publication Number Publication Date
ATE485374T1 true ATE485374T1 (de) 2010-11-15

Family

ID=36319307

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05803357T ATE485374T1 (de) 2004-11-02 2005-11-02 Lignan-glykosidase und deren nutzung

Country Status (7)

Country Link
US (1) US7935802B2 (de)
EP (1) EP1816193B1 (de)
JP (1) JP4667007B2 (de)
AT (1) ATE485374T1 (de)
DE (1) DE602005024295D1 (de)
DK (1) DK1816193T3 (de)
WO (1) WO2006049315A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008048612A (ja) * 2006-08-22 2008-03-06 Bio Taxol:Kk 糖転移酵素遺伝子
AU2008344534A1 (en) 2007-12-28 2009-07-09 Suntory Holdings Limited Lignan hydroxylase
JP5698663B2 (ja) * 2009-05-19 2015-04-08 サントリーホールディングス株式会社 フロフラン型リグナン４位グルコース転移酵素、及びそれをコードするポリヌクレオチド
CN102686273B (zh) 2009-12-30 2015-04-22 心脏起搏器公司 用于医疗电导线的终端连接器装置
WO2014086317A1 (zh) 2012-12-06 2014-06-12 中国科学院上海生命科学研究院 一组糖基转移酶及其应用
CN107267477B (zh) * 2017-05-16 2019-10-18 中国中医科学院中药研究所 新穿心莲内酯糖基转移酶蛋白及其编码基因与应用
CN113302298B (zh) 2018-11-09 2025-02-25 银杏生物制品公司 罗汉果甙的生物合成

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
JP4155607B2 (ja) 1996-04-23 2008-09-24 竹本油脂株式会社 セサミン類の分離方法
JP3585329B2 (ja) 1996-10-15 2004-11-04 東京瓦斯株式会社 フラボノイド配糖化酵素遺伝子
CA2270905A1 (en) 1996-11-08 1998-05-14 Washington State University Research Foundation Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use
JP3392668B2 (ja) * 1996-11-20 2003-03-31 中部飼料株式会社 ゴマリグナン物質とビタミンｅ類の強化卵、強化卵の製造法、および強化卵に基づく健康食品
EP1071754A4 (de) 1998-04-24 2001-08-29 Univ Washington Rekombinante secoisolariciresinol-dehydrogenase und verfahren für ihre verwendung.
JP3789699B2 (ja) 1999-11-18 2006-06-28 サントリー株式会社 リグナン系抗酸化剤及びその製造法
JP2002204666A (ja) * 2001-01-11 2002-07-23 Toyo Shinyaku:Kk ゴマ含有処方物
DE60329505D1 (de) 2002-08-20 2009-11-12 Suntory Holdings Ltd Neue glycosyltransferase-gene
JP2004344113A (ja) 2003-05-23 2004-12-09 Japan Science & Technology Agency ２，２−ビス（４−ヒドロキシフェニル）プロパン配糖化因子

Also Published As

Publication number Publication date
US20080293099A1 (en) 2008-11-27
WO2006049315A1 (ja) 2006-05-11
DK1816193T3 (da) 2011-01-31
JP4667007B2 (ja) 2011-04-06
JP2006129728A (ja) 2006-05-25
EP1816193B1 (de) 2010-10-20
EP1816193A4 (de) 2008-10-15
DE602005024295D1 (de) 2010-12-02
EP1816193A1 (de) 2007-08-08
US7935802B2 (en) 2011-05-03

Similar Documents

Publication Publication Date Title
ATE503009T1 (de) Polypeptide mit lipase-aktivität und diese kodierende polynukleotide
DK2333097T3 (da) Enzymer med alpha-amylase-aktivitet og fremgangsmåder til anvendelse deraf
ATE512980T1 (de) Polypeptide mit beta-glucosidase-aktivität sowie diese codierende polynukleotide
DE602006019050D1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
DE60325892D1 (de) Stellungs- und verwendungsverfahren
NO20063624L (no) FC region varianter
EP4219547A3 (de) Faktor-ix-polypeptidmutante, deren verwendungen und verfahren zu deren herstellung
BR0306955A (pt) variantes de protease com várias substituições
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
ATE471790T1 (de) Läppträger zur benutzung bei der herstellung von gleitkörpern
ATE517917T1 (de) Herstellung eines rekombinanten il-18-bindenden proteins
ATE485374T1 (de) Lignan-glykosidase und deren nutzung
ATE365464T1 (de) Getränk enthaltend geruchsneutralisierte sojaprotein-zusatzstoffe erhältlich mittels ein spezifisches verfahren, und herstellungsverfahren des getränks
ATE515568T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
UA101142C2 (ru) Способ разработки антитела
ATE315638T1 (de) Oxalacetat-hydrolase defiziente fungale wirtszellen
WO2006135793A3 (en) Protein engineering with analogous contact environments
ATE466079T1 (de) Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
DE602006010051D1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
ATE533837T1 (de) Microginin-produzierende proteine und nukleinsäuren, einen microginin gen-cluster kodierend, sowie methoden zur herstellung von microgininen
DE50110723D1 (de) Isolierte luziferasen sowie deren verwendung
ATE334208T1 (de) Menschliche proteasen und für diese kodierende polynukleotide
DE602004027086D1 (de) Klassifizierung von kolonkrebs
EP1760152A4 (de) Verfahren zur dipeptidherstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties